Amgen, Horizon Say FTC Is Reviewing Proposed $28B Merger
Law 360
JANUARY 31, 2023
biotechnology company Amgen Inc. and Ireland-based drugmaker Horizon Therapeutics PLC revealed in filings with the U.S. Securities and Exchange Commission on Monday that the Federal Trade Commission is reviewing their proposed $28 billion merger.
Let's personalize your content